Trials / Sponsors / Biocon Biologics UK Ltd
Biocon Biologics UK Ltd
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bma Moderate to Severe Chronic Plaque Psoriasis | Phase 1 | 2025-01-09 |
| Terminated | Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients | Phase 3 | 2025-01-06 |
| Completed | Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psor Moderate to Severe Chronic Plaque Psoriasis | Phase 3 | 2022-06-28 |
| Completed | Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmeno Postmenopausal Women With Osteoporosis | Phase 3 | 2022-05-24 |
| Completed | Comparison of Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Bmab 1000 and Prolia® in Normal Healthy Volunteers | Phase 1 | 2022-03-09 |